Chronic Lung Rejection
Chronic Lung Rejection - Related Videos
04:42
Picrosirius Red Staining for Semiquantitative Histopathologic Evaluation of Collagen Deposition in Murine Models of Chronic Lung Allograft Rejection
0 Views •
Cited by 1 •
2025
Picrosirius Red staining is a semiquantitative method for objectively assessing collagen deposition in murine pulmonary fibrotic remodeling in a spatially resolved manner. Apart from evaluating total collagen deposition, Picrosirius Red staining allows for differentiating collagen fibers of different thicknesses.
08:22
Orthotopic Left Lung Transplantation in Rats
0 Views •
Cited by 1 •
2025
This protocol describes an improved technique for orthotopic left lung transplantation in rats, focusing on reducing operational difficulty and improving survival rates.
16:26
Regulatory T cells: Therapeutic Potential for Treating Transplant Rejection and Type I Diabetes
0 Views •
Cited by 2 •
2007
10:01
Development of Obliterative Bronchiolitis in a Murine Model of Orthotopic Lung Transplantation
0 Views •
Cited by 20 •
2012
Obliterative bronchiolitis is the key impediment to the long-term survival of lung transplant recipients and the lack of a robust preclinical model precludes examining obliterative bronchiolitis immunopathogenesis. Unlike other solid organ transplants, vascularized mouse lung transplantation has only recently been developed. Here we show our independently developed obliterative bronchiolitis model after murine orthotopic single-lung transplantation.
FAQs
At the mechanistic level, recipient immune cells identify donor lung tissue as foreign and activate inflammatory cells and other immune pathways. This response injures graft structures, including the small airways, rather than representing a single isolated event. The biological importance is cumulative: repeated immune injury can progressively alter airway structure and impair airflow over time.
Repeated immune injury can narrow the airways and produce fibrosis, contributing to persistent loss of airflow. These structural changes help explain the progressive decline associated with chronic lung rejection and its classification within chronic lung allograft dysfunction. Functional deterioration therefore reflects accumulated graft damage, not only a temporary inflammatory response.
Immunosuppressive strategies matter because they are intended to limit the recipient’s damaging immune response and protect graft performance. The emphasis on better-targeted treatment connects mechanism to therapeutic design: researchers can ask whether an intervention reduces immune-mediated injury and helps preserve airflow. This approach links biological pathway studies with the long-term goal of extending transplantation benefits.
Lung-function monitoring provides a way to detect changes in graft performance over time, making it central to recognition of chronic lung rejection. Researchers can compare functional measurements across follow-up rather than relying on a single observation. A decline in airflow can signal clinically important progression and help identify patients who may need closer assessment or treatment evaluation.
Tissue analysis complements lung-function measurements by examining the graft itself for biological evidence of injury. This pairing connects an observable outcome, declining airflow, with underlying tissue changes that can include airway damage and fibrosis. In biology research, using both forms of evidence helps distinguish functional deterioration from the structural processes contributing to it.
Chronic lung rejection is important in transplant biology because it links immune recognition, inflammation, tissue remodeling, and organ-level function within one disease process. Studying these connections can support earlier recognition, improve understanding of chronic lung allograft dysfunction, and guide development of more precise immunosuppressive strategies. The desired outcome is preservation of graft performance and longer-lasting benefit after transplantation.